Showing results (431-440 of 510) with videos related to

Sort By:
Pageof 51
Neurology. Clinical Practice|October 14, 2024
Characterizing Prodrome (Premonitory Phase) in Migraine: Results From the PRODROME Trial Screening PeriodTodd J Schwedt, Richard B Lipton, Peter J Goadsby, et al.
Neurology|August 17, 2022
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe PainRichard B Lipton, David W Dodick, Peter J Goadsby, et al.
Headache|July 3, 2026
Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension studyDale S Bond, Jonathan H Smith, Alexandra Sinclair, et al.
Cephalalgia : an International Journal of Headache|June 22, 2011
The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristicsKrista A Payne, Sepideh F Varon, Ariane K Kawata, et al.
Cephalalgia : an International Journal of Headache|December 9, 2024
Weight loss with atogepant during the preventive treatment of migraine: A pooled analysisB Lee Peterlin, Dale S Bond, Jessica Ailani, et al.
Frontiers in Integrative Neuroscience|July 17, 2023
Visuo-spatial imagery in dreams of congenitally and early blind: a systematic reviewKatarina Ilic, Rita Bertani, Neda Lapteva, et al.
Neurobiology of Disease|December 21, 2013
Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: a Fos protein studyJungWook Park, HeuiSoo Moon, Simon Akerman, et al.
JAMA Neurology|May 19, 2025
Efficacy and Safety of Eptinezumab in Episodic Cluster Headache: A Randomized Clinical TrialRigmor H Jensen, Cristina Tassorelli, Stewart J Tepper, et al.
Headache|April 1, 2022
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative reviewDavid W Dodick, Peter J Goadsby, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache|March 9, 2011
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraineDavid J Hewitt, Sheena K Aurora, David W Dodick, et al.
Pageof 51